GRAIL, Inc.

GRAL · Healthcare

$80.34

Capitalización: 3.59B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar GRAIL, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Motley Fool4 sept 2026, 12:10

Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test

PR Newswire3 sept 2026, 20:02

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire31 ago 2026, 20:01

GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference

MarketBeat14 ago 2026, 7:04

GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting